Research Scientist
UIUC
Dr. Kannan Athilakshmi is a distinguished Research Scientist specializing in histology, immunohistochemistry (IHC), and reproductive physiology, with a particular focus on maternal-fetal interactions. She earned her Ph.D. in Chemistry from the Indian Institute of Technology, Chennai, India, and later pursued an M.S. in Comparative Biosciences at the University of Illinois, Urbana-Champaign. Her expertise lies in placental biology, endocrine disruption, and molecular diagnostics, making her a leading figure in the study of pregnancy-related complications.
Dr. Kannan has made significant contributions to understanding the cellular and molecular mechanisms that regulate maternal-fetal interactions during pregnancy. Her research has focused on:
Endocrine Disruptors and Pregnancy Outcomes:
She has extensively studied how environmental toxins, endocrine-disrupting chemicals (EDCs), and high-fat diets affect placental development and fetal health. Her findings have highlighted multi-generational pregnancy complications due to in utero exposure to chemicals like Di(2-ethylhexyl) phthalate (DEHP), shedding light on how these disrupt normal placental function and fetal growth.
Decidualization and Placental Development:
Dr. Kannan’s work has uncovered critical molecular pathways involved in endometrial receptivity and stromal differentiation, which are essential for successful implantation and placentation. She has played a pivotal role in identifying the role of transcription factors such as Runx1 and Runx2, which function downstream of Bone Morphogenetic Protein 2 (BMP2), in regulating uterine stromal cell differentiation and blood vessel formation at the maternal-fetal interface.
Immunological Aspects of Pregnancy:
Her studies have advanced our understanding of how maternal immune responses interact with developing placental structures. By investigating the expression of immune-modulating proteins in the placenta, she has helped elucidate how the maternal immune system accommodates fetal development while preventing rejection.
Multiplex Immunohistochemistry for Pregnancy-Related Biomarkers:
As an expert in tissue imaging and biomarker identification, Dr. Kannan has developed advanced immunohistochemistry protocols for detecting placental proteins, angiogenic factors, and hormone receptors crucial for fetal growth and placental health. Her pioneering work in phosphoprotein IHC and mass spectrometry-based IHC has allowed for precise localization of key signaling molecules within the placenta, aiding in early diagnosis of pregnancy disorders.
Pathways Underlying Pregnancy Disorders:
Dr. Kannan has contributed to identifying biomarkers and molecular mechanisms underlying pregnancy complications such as pre-eclampsia, intrauterine growth restriction (IUGR), and recurrent pregnancy loss. Her research has demonstrated how disruptions in the progesterone receptor signaling pathway, C/EBPβ transcription factor, and estrogen biosynthesis critically impact placental development and function.
Impact and Recognition
Dr. Kannan’s work has had a lasting impact on maternal-fetal medicine, toxicology, and reproductive biology. Her contributions have been recognized through:
Invited talks at major scientific conferences, including the National Society for Histotechnology (NSH) and the Society for the Study of Reproduction (SSR).
Award-winning research on the effects of tissue fixation on phosphoprotein IHC, the role of endocrine disruptors in pregnancy, and novel fixation protocols for histopathology.
Peer-reviewed publications in high-impact journals, contributing to new diagnostic and therapeutic approaches for pregnancy complications.
Mentorship of undergraduate, graduate, and postdoctoral researchers, fostering the next generation of scientists in reproductive and placental biology.